Intellectual Property India Publishes Patent Application for 'System And Method For Converting Adipose Derived Mesenchymal Stem Cells To Hematopoietic Stem/Progenitor Cells And Differentiating Into Blood Cells And Applications Of Same' Filed by Ul Cell Therapeutic Pte. Ltd.

MUMBAI, India, Oct. 31 -- Intellectual Property India has published a patent application (202517093795 A) filed by Ul Cell Therapeutic Pte. Ltd., Singapore, on Sept. 30, for 'system and method for converting adipose derived mesenchymal stem cells to hematopoietic stem/progenitor cells and differentiating into blood cells and applications of same.'

Inventor(s) include Li, Wei; You, Shaojin; Lin, Michael Chengnan; and You, Annie.

The application for the patent was published on Oct. 31, under issue no. 44/2025.

According to the abstract released by the Intellectual Property India: "A method of producing hematopoietic stem/progenitor cells (HS/PCs) and blood cells from adipose derived mesenchymal stem cells (Ad MSCs). The method comprises obtaining biological cells of a subject; expanding the biological cells; obtaining a pure Ad MSCs cell line from the expanded biological cells; converting the pure Ad MSCs cell line into HS/PCs in vitro; expanding the converted HS/PCs in vitro; and obtaining the expanded HS/PCs."

The patent application was internationally filed on Mar. 11, 2024, under International application No.PCT/US2024/019327.

Disclaimer: Curated by HT Syndication.